Stockreport

Century Therapeutics: A Biotech With Interesting Optionality Opportunities [Seeking Alpha]

Century Therapeutics, Inc.  (IPSC) 
PDF IPSC pivoted from oncology to autoimmune CAR cells and CNTY-813 for Type 1 diabetes, now the pipeline's main value driver. Recent management actions reduced quarterly [Read more]